Ferndale Laboratories, Inc. v. Schwarz Pharma, Inc.

**The Dispute** This case involved a business contract dispute between two pharmaceutical companies, Ferndale Laboratories and Schwarz Pharma, along with an individual named Block. Ferndale claimed that Block breached a contract and that Schwarz Pharma unfairly benefited from this breach. The case went to trial where Ferndale initially won significant damages. **The Court's Decision** The appeals court gave Ferndale a mixed victory. While the court agreed that Block did breach the contract and Schwarz Pharma was liable for unjust enrichment, it dramatically reduced the financial awards. The court cut Block's damages from $8.3 million down to just $216,499 and completely eliminated the damages award against Schwarz Pharma. The case was sent back to the lower court for further review on the damages issues. **What This Means for Workers** This case demonstrates that even when employees or former employees are found to have breached their contracts, the actual financial consequences can vary greatly depending on how courts calculate damages. It shows that initial trial victories don't always hold up on appeal, and damage awards can be significantly reduced or eliminated entirely when higher courts review the evidence.